Psychotropic medicine use in the disability sector

0
Psychotropic medicines are ‘overused and misused’ in the disability sector, consultant pharmacist Dr Manya Angley FPS told the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability yesterday.

All the action from PSA22 – Day 3

0
At the final day of PSA22, attendees boosted their knowledge of poisons control and supporting transgender patients.

The cardiovascular crisis needs a pharmacy-led response

0
Pharmacists have numerous opportunities to assess risk, recommend therapies, and help patients manage their heart health.

Breathing new life into COPD diagnosis and treatment

0
Prevention, early diagnosis and optimal treatment are essential to reduce the progression of this irreversible disease.

What new data privacy laws mean for pharmacies

0
In February, the Federal Government substantially increased responsibilities around personal data for businesses who handle it, with healthcare providers given particular focus. So what...

Former CMO Brendan Murphy on leading through a pandemic

0
Dealing with challenging situations and weighing up the best available evidence is a familiar scenario for medical professionals. But for Professor Brendan Murphy, who led the health response to the COVID-19 pandemic, the scope of the challenge – and the evidence — changed constantly.